The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
36 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,472,267 in first-year total cost, median $184,880.
Most frequent study sections
- Transition to Independence Study Section (I)[NCI-I]21
- Special Emphasis Panel[ZCA1 RTRB-A (M2)]7
- Special Emphasis Panel[ZCA1 RTRB-K (J1)]7
- Special Emphasis Panel[ZCA1 RTRB-A (O1)]1
Most frequent institutions
- STATE UNIVERSITY NEW YORK STONY BROOK3
- UNIVERSITY OF NEBRASKA MEDICAL CENTER3
- UNIVERSITY OF SOUTHERN CALIFORNIA2
- AMERICAN UNIVERSITY1
- BOSTON UNIVERSITY MEDICAL CAMPUS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Metabolic liabilities of cancer cells to the tumor nutrient environment1K22CA193660-01 | BIRSOY, KIVANC | ROCKEFELLER UNIVERSITY, NY | $206,064 | NCI |
| 2016 | Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma1K22CA197014-01 | YANG, YIBIN | RESEARCH INST OF FOX CHASE CAN CTR, PA | $194,616 | NCI |
| 2016 | PCOS, Type II diabetes and ovarian cancer risk1K22CA193860-01 | HARRIS, HOLLY RUTH | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $184,615 | NCI |
| 2016 | BACH2 in Melanoma Development and Resistance1K22CA197058-01 | KARRETH, FLORIAN | H. LEE MOFFITT CANCER CTR & RES INST, FL | $177,344 | NCI |
| 2016 | p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer1K22CA190653-01A1 | ALEXANDROVA, EVGUENIA | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $157,743 | NCI |
| 2016 | Exosomic microRNAs and drug resistance in AML tumor microenvironment1K22CA197074-01 | CHALLAGUNDLA, KISHORE B. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $154,958 | NCI |
| 2016 | Roles of Spartan in translesion synthesis and UV-induced carcinogenesis1K22CA188181-01A1 | GHOSAL, GARGI | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $133,898 | NCI |
| 2015 | Clonal analysis of epithelial stem cells in prostate regeneration and cancer1K22CA188169-01 | TALOS, FLAMINIA | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $219,866 | ZCA1 |
| 2015 | The role of autophagy in Kras-driven lung cancer1K22CA190521-01A1 | GUO, YANXIANG | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $209,628 | NCI |
| 2015 | Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells1K22CA197053-01 | BADR, CHRISTIAN ELIAS | MASSACHUSETTS GENERAL HOSPITAL, MA | $200,880 | NCI |
| 2015 | Juxtacrine regulation of metastasis from brain microenvironments1K22CA181470-01 | CHEN, QING | WISTAR INSTITUTE, PA | $195,990 | NCI |
| 2015 | Identification of Novel Mechanisms of Autophagy Regulation for Cancer1K22CA187931-01 | STROHECKER, ANNE M | OHIO STATE UNIVERSITY, OH | $193,428 | ZCA1 |
| 2015 | Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance1K22CA193674-01 | LIN, YI | MAYO CLINIC ROCHESTER, MN | $192,485 | NCI |
| 2015 | Noxa-mediated mechanisms of proteasome addiction in basal-like breast cancer1K22CA184244-01 | PETROCCA, FABIO | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $191,808 | ZCA1 |
| 2015 | Online monitoring and image-guided treatment of chemoresistant micrometastases1K22CA181611-01A1 | SPRING, BRYAN QUILTY | NORTHEASTERN UNIVERSITY, MA | $186,276 | NCI |
| 2015 | Roles of CD2 and 2B4 in invariant natural killer T (iNKT) cell functions.1K22CA188149-01 | DAS, RUPALI | MICHIGAN STATE UNIVERSITY, MI | $185,144 | ZCA1 |
| 2015 | The Role Of p97-Chaperone Complexes In Protein Quality Control1K22CA175142-01 | RAMAN, MALAVIKA | TUFTS UNIVERSITY BOSTON, MA | $180,166 | NCI |
| 2015 | The mechanism and function of cell competition in tumors1K22CA190440-01 | LI, WEI | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $175,424 | NCI |
| 2015 | PSMA Targeted Docetaxel Loaded Magnetic Nanoparticles for Prostate Cancer Therapy1K22CA174841-01A1 | YALLAPU, MURALI MOHAN | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $162,378 | NCI |
| 2015 | Targeting defective DNA repair for the prevention of BRCA1-associated cancers1K22CA181550-01 | ALLI, ELIZABETH | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $162,000 | ZCA1 |
| 2015 | Characterization of replication-mediated DNA damage in B lymphocytes1K22CA188106-01 | BARLOW, JACQUELINE | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $162,000 | ZCA1 |
| 2015 | A Novel Protein Complex Controls Homologous Recombination Repair in Breast Cancer1K22CA178317-01A1 | YUAN, JINGSONG | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $161,996 | ZCA1 |
| 2015 | Dissecting Genetic and Epigenetic variation in the Cancer Regulome1K22CA184308-01 | HODGES, EMILY | VANDERBILT UNIVERSITY, TN | $157,854 | ZCA1 |
| 2015 | Parental Exposure to High Fats Diets and Risk of Pancreatic Cancer in the Offspri1K22CA178309-01A1 | DE ASSIS, SONIA | GEORGETOWN UNIVERSITY, DC | $153,035 | ZCA1 |
| 2014 | Deciphering the role of ubiquitination in regulating EMT and Cancer Stem Cell1K22CA181412-01 | CHAN, CHIA-HSIN (LORI) | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $219,758 | NCI |
| 2014 | Molecular mechanism of RNA polymerase I transcription and dysregulation in cancer1K22CA184235-01 | KNUTSON, BRUCE ALAN | UPSTATE MEDICAL UNIVERSITY, NY | $211,470 | ZCA1 |
| 2014 | Characterizing the role of TAK1 in breast cancer metastasis1K22CA175228-01A1 | YU, MIN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $197,424 | NCI |
| 2014 | Defining the genetic requirements for maintenance of colorectal cancer1K22CA181280-01 | DOW, LUKAS EDWARD | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $194,724 | NCI |
| 2014 | Silencing of Mobile Genetic Elements by Small RNAs1K22CA177897-01 | PHILLIPS, CAROLYN MARIE | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $191,709 | NCI |
| 2014 | Assessing BIM expression as a cause and marker for resistance to targeted therapi1K22CA175276-01 | FABER, ANTHONY CHARLES | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $191,067 | NCI |
| 2014 | Improving Healthcare Providers' Communication about HPV Vaccine1K22CA186979-01 | GILKEY, MELISSA B | HARVARD PILGRIM HEALTH CARE, INC., MA | $187,368 | ZCA1 |
| 2014 | Proliferation-quiescence control by integration of stress and mitogen signaling1K22CA188144-01 | SPENCER, SABRINA LEIGH | UNIVERSITY OF COLORADO, CO | $184,267 | ZCA1 |
| 2014 | DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCER1K22CA188163-01 | GRIFFITH, OBI L. | WASHINGTON UNIVERSITY, MO | $171,745 | ZCA1 |
| 2014 | Metabolic reprogramming in liver cancer cells by a novel tumor suppressor1K22CA184146-01 | ZHANG, YUXIA | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $150,228 | ZCA1 |
| 2014 | Model systems for the investigation of DNA methylation and drug repurposing1K22CA184297-01 | BRACHT, JOHN RUSSELL | AMERICAN UNIVERSITY, DC | $149,633 | ZCA1 |
| 2014 | PD2/Paf1 and pancreatic cancer stem cells1K22CA175260-01A1 | PONNUSAMY, MOORTHY P. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $123,278 | NCI |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.